Tissue Regenix Group Plc (TRX) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.11x

Tissue Regenix Group Plc (TRX) has a Cash Flow Reinvestment Rate of 0.11x as of December 2023, reinvesting GBX153.75K (capex GBX153.75K ) from operating cash flow of GBX1.36 Million. Explore Tissue Regenix Group Plc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.11x

(Capex + Investments) / Operating CF

Total Reinvested

GBX153.75K

Capex + Investments

Operating Cash Flow

GBX1.36 Million

GBX

Capital Expenditures

GBX153.75K

GBX

Tissue Regenix Group Plc Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for Tissue Regenix Group Plc across 1 annual periods. Also explore Tissue Regenix Group Plc asset portfolio for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Tissue Regenix Group Plc (2023–2023)

Year-by-year capital reinvestment analysis for Tissue Regenix Group Plc. For live market cap and broader valuation context, see Tissue Regenix Group Plc stock valuation.

Year	Reinvestment Rate	Total Reinvested (GBX)	Operating CF	Capex	YoY Change
2023	1.63x	GBX1.70 Million	GBX1.04 Million	GBX863.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow